Insurance Regulatory asks insurers to formulate rates for Covid treatment
The Insurance Regulatory and Development Authority of India (IRDAI) has advised general and health insurers to have agreements with health providers on rates for treatment of Covid-19 on the lines of other diseases.
While entering into such agreements, insurance companies can refer to the rates provided by the General Insurance Council in June, along with the rates fixed by state governments and Union territory administration, if any, it said. “In case of 'cashless claims' under a health insurance policy, the claims shall be settled as per the tariff decided by the parties in compliance to provisions of Regulation 31 of IRDAI (Health Insurance) Regulations, 2016," the regulator added.
After the outbreak of COVID-19 pandemic, insurance companies had started receiving higher-than-expected claims as hospitals were charging higher rates for such treatments as compared to other diseases. To standardize the rates for COVID-19 treatment, the General Insurance Council had in June, introduced a reference rate for COVID19 treatments, taking into account rates published by various state governments and also after discussions with health claims experts. The regulator said insurance companies have to ensure that "reimbursement claims" under a health insurance policy are settled as per the terms and conditions of the policy contract. "Insurers are advised to issue suitable guidelines on this to all TPAs (third-party administrators)," it added.
Source: News Track